Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;136(6):1120-5.
doi: 10.1016/j.thromres.2015.10.004. Epub 2015 Oct 8.

Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis

A J Tafur  1 , G Dale  2 , M Cherry  3 , J D Wren  4 , A S Mansfield  5 , P Comp  3 , S Rathbun  2 , J A Stoner  6
Affiliations

Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis

A J Tafur et al. Thromb Res. 2015 Dec.

Abstract

Venous thromboembolism (VTE) is a preventable disease, yet it is one of the leading causes of death among patients with cancer. Improving risk stratification mechanisms will allow us to personalize thrombo-prophylaxis strategies. We sought to evaluate Collagen and Thrombin Activated Platelets (COAT-platelets) as well as protein C and factor VIII as biomarkers predictive of cancer-associated thrombosis in a prospective cohort of patients with cancer. Protein C was selected as a candidate based on bioinformatics prediction. Blood samples were collected before chemotherapy. All specimen processing was blinded to clinical data. Surveillance and adjudication of the main outcome of VTE was performed for up to 1 year. We used Cox proportional hazard regression to measure the association of biomarkers and incident events using SAS 9.2 for all statistical analysis. Death was modeled as a competing event. Among 241 patients followed for an average of 10.4 months, 15% died and 13% developed a VTE. COAT-platelets were not predictive of VTE. Low levels of pre-chemotherapy protein C (<118%) (HR 2.5; 95% CI 1.1-5.5) and high baseline factor VIII (>261% I) (HR 3.0; 95% CI 1.1-8.0) were predictive of VTE after adjusting for age, Khorana prediction risk, metastatic disease and D dimer. In addition, low protein C was predictive of overall mortality independent of age, metastatic disease and functional status (HR 2.8; 95% CI 1.3-6.0). Addition of these biomarkers to cancer-VTE risk prediction models may add to risk stratification and patient selection to optimize thrombo-prophylaxis.

Keywords: Bioinformatics; Biomarkers; Cancer; Venous thromboembolism.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Protein C and Cancer-associated Venous thromboembolism
Kaplan Meier curve of the probability of thrombosis-free survival among patients with cancer. Log rank used for statistical testing.
Figure 2
Figure 2. Factor VIII and Cancer-associated Venous Thromboembolism
Kaplan Meier curve of the probability of thrombosis free survival among patients with cancer. Log rank used for statistical testing. Factor VIII is presented as % of activity.
See this image and copyright information in PMC

References

    1. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Journal of thrombosis and haemostasis: JTH. 2007;5:632–4. doi: 10.1111/j.1538-7836.2007.02374.x. - DOI - PubMed
    1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ., 3rd Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Archives of internal medicine. 2000;160:809–15. - PubMed
    1. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846–50. doi: 10.1056/NEJM200012213432504. - DOI - PubMed
    1. Kourelis TV, Wysokinska EM, Wang Y, Yang P, Mansfield AS, Tafur AJ. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer. Lung Cancer. 2014;86:358–62. doi: 10.1016/j.lungcan.2014.10.003. - DOI - PMC - PubMed
    1. Tafur AJ, Wysokinski WE, McBane RD, Wolny E, Sutkowska E, Litin SC, Daniels PR, Slusser JP, Hodge DO, Heit JA. Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO. 2012;23:1998–2005. doi: 10.1093/annonc/mds058. - DOI - PubMed

Publication types

LinkOut - more resources